These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 8091356

  • 1. [Calcium antagonists and the central nervous system].
    Allain H, Bentué-Ferrer D, Saiag B, Belliard S, Thaminy S.
    Therapie; 1993; 48 Spec No():697-705. PubMed ID: 8091356
    [Abstract] [Full Text] [Related]

  • 2. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A, Mathy MJ, Balt JC, Pfaffendorf M, van Zwieten PA.
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [Abstract] [Full Text] [Related]

  • 3. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
    Biessels GJ, ter Laak MP, Kamal A, Gispen WH.
    Brain Res; 2005 Feb 21; 1035(1):86-93. PubMed ID: 15713280
    [Abstract] [Full Text] [Related]

  • 4. Tiapamil, a new calcium antagonist. 2. Further pharmacological characterization and toxicology.
    Eigenmann R, Gerold M, Hefti F, Jovanovic D, Haeusler G.
    Arzneimittelforschung; 1981 Feb 21; 31(9):1401-10. PubMed ID: 7197946
    [No Abstract] [Full Text] [Related]

  • 5. Redundancy of Cav2.1 channel accessory subunits in transmitter release at the mouse neuromuscular junction.
    Kaja S, Todorov B, van de Ven RC, Ferrari MD, Frants RR, van den Maagdenberg AM, Plomp JJ.
    Brain Res; 2007 Apr 27; 1143():92-101. PubMed ID: 17320843
    [Abstract] [Full Text] [Related]

  • 6. [The effect of the subchronic administration of calcium-channel blockers on CNS excitability].
    Kozlovskiĭ VL, Mosin AE, Ivakina LV.
    Eksp Klin Farmakol; 1996 Apr 27; 59(1):14-6. PubMed ID: 8704622
    [Abstract] [Full Text] [Related]

  • 7. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H, Kuwahara K, Takano M, Arai Y, Kuwabara Y, Yasuno S, Nakagawa Y, Nakanishi M, Harada M, Fujiwara M, Murakami M, Ueshima K, Nakao K.
    Circulation; 2009 Sep 01; 120(9):743-52. PubMed ID: 19687356
    [Abstract] [Full Text] [Related]

  • 8. L-type calcium channels reduce ROS generation in cerebellar granule cells following kainate exposure.
    Leski ML, Hassinger LC, Valentine SL, Baer JD, Coyle JT.
    Synapse; 2002 Jan 01; 43(1):30-41. PubMed ID: 11746731
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological actions of aminopyridines and related compounds.
    Bowman WC, Savage AO.
    Rev Pure Appl Pharmacol Sci; 1981 Jan 01; 2(4):317-71. PubMed ID: 6278543
    [No Abstract] [Full Text] [Related]

  • 10. Static magnetic field expose enhances neurotransmission in crayfish nervous system.
    Yeh SR, Yang JW, Lee YT, Tsai LY.
    Int J Radiat Biol; 2008 Jul 01; 84(7):561-7. PubMed ID: 18661372
    [Abstract] [Full Text] [Related]

  • 11. [Action of anesthetics on neurotransmission in the central nervous system. Review].
    Rodríguez Vila D, Martí Viaño JL.
    Rev Esp Anestesiol Reanim; 1978 Jul 01; 25(4):317-28. PubMed ID: 211564
    [No Abstract] [Full Text] [Related]

  • 12. Presynaptic calcium channels: structure, regulators, and blockers.
    Kisilevsky AE, Zamponi GW.
    Handb Exp Pharmacol; 2008 Jul 01; (184):45-75. PubMed ID: 18064411
    [Abstract] [Full Text] [Related]

  • 13. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T, Ukai K, Masuda T, Nakagawa T, Kimura K, Fujii M, Wakatsuki K, Saeki M, Kasai H.
    Arzneimittelforschung; 1997 Dec 01; 47(12):1375-82. PubMed ID: 9450167
    [Abstract] [Full Text] [Related]

  • 14. Suppression of L-type voltage-gated calcium channel-dependent synaptic plasticity by ethanol: analysis of miniature synaptic currents and dendritic calcium transients.
    Hendricson AW, Thomas MP, Lippmann MJ, Morrisett RA.
    J Pharmacol Exp Ther; 2003 Nov 01; 307(2):550-8. PubMed ID: 12970385
    [Abstract] [Full Text] [Related]

  • 15. [Calcium antagonists and ischemic heart disease].
    Simon K, Vályi P, Szépvölgyi A, Badics A, Böhm T.
    Orv Hetil; 1996 Sep 29; 137(39):2131-6. PubMed ID: 8927361
    [Abstract] [Full Text] [Related]

  • 16. Spontaneous astrocytic Ca2+ oscillations in situ drive NMDAR-mediated neuronal excitation.
    Parri HR, Gould TM, Crunelli V.
    Nat Neurosci; 2001 Aug 29; 4(8):803-12. PubMed ID: 11477426
    [Abstract] [Full Text] [Related]

  • 17. [Some pharmacological properties of pyrogallol].
    Lastowski Z.
    Ann Univ Mariae Curie Sklodowska Med; 1968 Aug 29; 23():115-20. PubMed ID: 5745728
    [No Abstract] [Full Text] [Related]

  • 18. General pharmacological profile and effects of E-4716, a novel histamine receptor blocker, on the central nervous system.
    Fisas MA, Gutiérrez B, Fort M, Dordal A, García C, Farré AJ.
    Methods Find Exp Clin Pharmacol; 1998 Apr 29; 20(3):199-210. PubMed ID: 9646282
    [Abstract] [Full Text] [Related]

  • 19. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system.
    Pickering M, Cumiskey D, O'Connor JJ.
    Exp Physiol; 2005 Sep 29; 90(5):663-70. PubMed ID: 15944202
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.
    Teodori E, Baldi E, Dei S, Gualtieri F, Romanelli MN, Scapecchi S, Bellucci C, Ghelardini C, Matucci R.
    J Med Chem; 2004 Nov 18; 47(24):6070-81. PubMed ID: 15537361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.